Natixis Advisors, L.P. Vertex Pharmaceuticals Inc Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 461,886 shares of VRTX stock, worth $195 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

461,886

Previous 436,585 5.8%

Holding current value

$195 Million

Previous $205 Million 4.97%

% of portfolio

0.42%

Previous 0.44%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$460.0 - $505.78 $11.6 Million - $12.8 Million	25,301 Added 5.8%	461,886 $215 Million
Q2 2024 Aug 01, 2024	BUY	$392.81 - $485.53 $41.1 Million - $50.7 Million	104,522 Added 31.48%	436,585 $205 Million
Q1 2024 Apr 25, 2024	BUY	$407.69 - $446.08 $5.13 Million - $5.61 Million	12,587 Added 3.94%	332,063 $139 Million
Q4 2023 Feb 06, 2024	BUY	$343.0 - $410.68 $91,238 - $109,240	266 Added 0.08%	319,476 $130 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $52.1 Million - $55.8 Million	-153,998 Reduced 32.54%	319,210 $111 Million
Q2 2023 Aug 15, 2023	BUY	$314.42 - $351.91 $3.21 Million - $3.6 Million	10,220 Added 2.21%	473,208 $167 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $1.23 Million - $1.4 Million	-4,344 Reduced 0.93%	462,988 $146 Million
Q4 2022 Jan 27, 2023	SELL	$285.76 - $321.48 $11.7 Million - $13.2 Million	-41,088 Reduced 8.08%	467,332 $135 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $26.2 Million - $29.3 Million	-95,775 Reduced 15.85%	508,420 $147 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $15.6 Million - $19.4 Million	-66,323 Reduced 9.89%	604,195 $170 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $601,376 - $708,794	2,716 Added 0.41%	670,518 $175 Million
Q4 2021 Feb 08, 2022	BUY	$177.01 - $223.45 $9.04 Million - $11.4 Million	51,094 Added 8.28%	667,802 $147 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $74 Million - $82.8 Million	407,937 Added 195.4%	616,708 $112 Million
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $7.06 Million - $8.33 Million	37,665 Added 22.01%	208,771 $42.1 Million
Q1 2021 May 05, 2021	BUY	$207.02 - $241.31 $6.34 Million - $7.39 Million	30,638 Added 21.81%	171,106 $36.8 Million
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $14.4 Million - $19.2 Million	-69,574 Reduced 33.12%	140,468 $33.2 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $3.35 Million - $3.97 Million	13,085 Added 6.64%	210,042 $57.2 Million
Q2 2020 Aug 11, 2020	BUY	$225.48 - $295.8 $9.18 Million - $12 Million	40,730 Added 26.07%	196,957 $57.2 Million
Q1 2020 Apr 27, 2020	BUY	$199.77 - $247.81 $3.38 Million - $4.19 Million	16,901 Added 12.13%	156,227 $37.2 Million
Q4 2019 Feb 10, 2020	BUY	$166.71 - $223.91 $176,712 - $237,344	1,060 Added 0.77%	139,326 $30.5 Million
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $1.44 Million - $1.62 Million	8,660 Added 6.68%	138,266 $23.4 Million
Q2 2019 Aug 12, 2019	BUY	$164.61 - $190.37 $1.41 Million - $1.63 Million	8,585 Added 7.09%	129,606 $23.8 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $1.33 Million - $1.59 Million	-8,150 Reduced 6.31%	121,021 $22.3 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $437,652 - $553,757	2,881 Added 2.28%	129,171 $21.4 Million
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $1.71 Million - $1.97 Million	10,203 Added 8.79%	126,290 $24.3 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $5.37 Million - $6.26 Million	36,853 Added 46.51%	116,087 $0
Q1 2018 May 10, 2018	SELL	$151.6 - $177.13 $3,183 - $3,719	-21 Reduced 0.03%	79,234 $12.9 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $395,640 - $448,295	-2,882 Reduced 3.51%	79,255 $11.9 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $12.2 Million - $13.3 Million	82,137	82,137 $12.5 Million

Others Institutions Holding VRTX

# of Institutions

1,718

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $108B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Vertex Pharmaceuticals Inc Transaction History